Miriam N. Lango

3.3k total citations
98 papers, 2.3k citations indexed

About

Miriam N. Lango is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Miriam N. Lango has authored 98 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Otorhinolaryngology, 41 papers in Oncology and 38 papers in Surgery. Recurrent topics in Miriam N. Lango's work include Head and Neck Cancer Studies (48 papers), Cancer Diagnosis and Treatment (17 papers) and Lung Cancer Treatments and Mutations (11 papers). Miriam N. Lango is often cited by papers focused on Head and Neck Cancer Studies (48 papers), Cancer Diagnosis and Treatment (17 papers) and Lung Cancer Treatments and Mutations (11 papers). Miriam N. Lango collaborates with scholars based in United States, Canada and Russia. Miriam N. Lango's co-authors include John A. Ridge, Thomas J. Galloway, Wayne M. Koch, David Sidransky, Barbara Burtness, Jennifer R. Grandis, Ranee Mehra, Marianna Zahurak, Duane A. Sewell and Sichuan Xi and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Miriam N. Lango

95 papers receiving 2.3k citations

Peers

Countries citing papers authored by Miriam N. Lango

Since Specialization

Citations

This map shows the geographic impact of Miriam N. Lango's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam N. Lango with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam N. Lango more than expected).

Fields of papers citing papers by Miriam N. Lango

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam N. Lango. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam N. Lango. The network helps show where Miriam N. Lango may publish in the future.

Co-authorship network of co-authors of Miriam N. Lango

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam N. Lango. A scholar is included among the top collaborators of Miriam N. Lango based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam N. Lango. Miriam N. Lango is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck 2025 ·Head & Neck ·Aarti Bhatia, Ranee Mehra, Jessica R. Bauman, Saad A. Khan, Wei Wei, Veronique Neumeister, Teresa Sandoval-Schaefer, R. Katherine Alpaugh, Miriam N. Lango, David L. Rimm, John A. Ridge, Barbara Burtness	2
2	Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer 2025 ·Journal of Clinical Oncology ·Barbara Burtness, Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, (unknown), Seungwon Kim, Bert W. O’Malley, Enver Özer, Chukwuemeka Ikpeazu, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Mihir R. Patel, Miriam N. Lango, Luc G.T. Morris, Russell K. Smith, Daniel W. Karakla, Jeremy D. Richmon, F. Christopher Holsinger, Robert L. Ferris	4
3	Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis 2024 ·Otolaryngology ·(unknown), Amy C. Moreno, Yun Qing, J. Jack Lee, Faye M. Johnson, Miriam N. Lango, Carly E. A. Barbon, (unknown), (unknown), (unknown), Neil D. Gross, Clifton D. Fuller, Stephen Y. Lai, Jeffrey N. Myers, Katherine A. Hutcheson	3
4	Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group. 2024 ·Journal of Clinical Oncology ·Barbara Burtness, Yael Flamand, Harry Quon, Gregory S. Weinstein, Ranee Mehra, Joaquín J. García, Seungwon Kim, Bert W. O’Malley, Enver Özer, Wayne M. Koch, Neil D. Gross, R. Bryan Bell, Mihir R. Patel, Miriam N. Lango, (unknown), Russell K. Smith, Daniel W. Karakla, Jeremy D. Richmon, F. Christopher Holsinger, Robert L. Ferris	4
5	Impact of primary tumor‐specific growth rate on treatment failure for nonoropharyngeal head and neck cancers 2019 ·The Laryngoscope ·(unknown), (unknown), (unknown), (unknown), Thomas M. Churilla, Miriam N. Lango, Thomas J. Galloway	3
6	Diverging incidence trends for larynx and tonsil cancer in low socioeconomic regions of the US 2019 ·Oral Oncology ·Jessica A. Tang, Miriam N. Lango	10
7	Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer 2019 ·Oral Oncology ·Yanqun Dong, John A. Ridge, Barbara Ebersole, Tianyu Li, Miriam N. Lango, Thomas M. Churilla, (unknown), Jessica R. Bauman, Thomas J. Galloway	33
8	Otolaryngology-Related Disorders in Underserved Populations, Otolaryngology Training and Workforce Considerations in North America 2018 ·Otolaryngologic Clinics of North America ·Brian D. Westerberg, Miriam N. Lango	7
9	Patterns of Initial Therapy for Larynx Cancer in Elderly Patients: A Population Based Analysis 2017 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), T.M. Churilla, Jessica R. Bauman, Miriam N. Lango, Brian L. Egleston, Thomas J. Galloway	1
10	The Role of Occupational Voice Demand and Patient-Rated Impairment in Predicting Voice Therapy Adherence 2017 ·Journal of Voice ·Barbara Ebersole, (unknown), Kathleen Moran, Miriam N. Lango, Karthik Devarajan, Nausheen Jamal	18
11	Long-Term Toxicities in Survivors of Radiation Treatment for Head and Neck Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), T.M. Churilla, Ranee Mehra, Miriam N. Lango, Jessica R. Bauman, John A. Ridge, Thomas J. Galloway	0
12	EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer 2016 ·Molecular Cancer Therapeutics ·Tim N. Beck, (unknown), Elena Shagisultanova, (unknown), Elizabeth A. Handorf, Cara Dubyk, Miriam N. Lango, John A. Ridge, Igor Astsaturov, Ilya G. Serebriiskii, Barbara Burtness, Ranee Mehra, Erica A. Golemis	44
13	Unilateral Vocal Cord Motion Impairment After 1 Dose of Vincristine 2015 ·American Journal of Therapeutics ·(unknown), (unknown), Miriam N. Lango	2
14	Asymptomatic Deep Peroneal Vein Thrombosis During Free Fibula Flap Harvest 2014 ·Annals of Plastic Surgery ·Sameer A. Patel, Hamid Abdollahi, John A. Ridge, Eric I. Chang, Miriam N. Lango, Neal S. Topham	7
15	Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers 2013 ·Clinical Cancer Research ·Ranee Mehra, Fang Zhu, Dong‐Hua Yang, Kathy Q. Cai, JoEllen Weaver, Mahendra Singh, Anna S. Nikonova, Erica A. Golemis, Douglas B. Flieder, Harry S. Cooper, Miriam N. Lango, John A. Ridge, Barbara Burtness	21
16	Unilateral neck therapy in the human papillomavirus ERA: Accepted regional spread patterns 2012 ·Head & Neck ·Thomas J. Galloway, Miriam N. Lango, Barbara Burtness, Ranee Mehra, Karen Ruth, John A. Ridge	10
17	Initial Results of a Phase I Dose-Escalation Trial of Concurrent and Maintenance Erlotinib and Reirradiation for Recurrent and New Primary Head-and-Neck Cancer 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Kyle E. Rusthoven, Steven J. Feigenberg, David Raben, Madeleine Kane, John I. Song, Nicos Nicolaou, Ranee Mehra, Barbara Burtness, John A. Ridge, (unknown), Miriam N. Lango, Roger B. Cohen, Antonio Jimeno, Changhu Chen	21
18	Increased Recurrences Using Intensity-Modulated Radiation Therapy in the Postoperative Setting 2010 ·American Journal of Clinical Oncology ·Aruna Turaka, Tianyu Li, Navesh Sharma, Linna Li, Nicos Nicolaou, Ranee Mehra, Barbara Burtness, Roger B. Cohen, Miriam N. Lango, Eric M. Horwitz, John A. Ridge, Steven J. Feigenberg	13
19	Impact of neck dissection on long‐term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation 2009 ·Head & Neck ·Miriam N. Lango, Brian L. Egleston, Kevin Ende, Steven J. Feigenberg, David D’Ambrosio, Roger B. Cohen, (unknown), Nicos Nicolaou, John A. Ridge	51
20	Controversies in Surgical Management of the Node-Positive Neck After Chemoradiation 2008 ·Seminars in Radiation Oncology ·Miriam N. Lango, Jeffrey N. Myers, Adam S. Garden	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact